3,411
Participants
Start Date
September 4, 2020
Primary Completion Date
August 10, 2021
Study Completion Date
December 3, 2021
MR or M-M-R II ® vaccine
Education and surveillance plus MR or M-M-R II ® vaccine
Placebo
Placebo injection
Aurum Institute Tembisa, Tembisa
Perinatal HIV Research Unit (PHRU), Diepkloof
Wits RHI, University of the Witwatersrand, Hillbrow
Clinical HIV Research Unit (CHRU), Auckland Park
Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth
Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban
FAMCRU (Family Clinical Research with Ubuntu), Cape Town
Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray
Groote Schuur Hospital, Cape Town
Masiphumelele, Desmond Tutu Health Foundation, Sunnydale
JOSHA Research, Bloemfontein
Levy Mwanawasa University Teaching Hospital, Lusaka
Washington University School of Medicine, St Louis
University of Ghana Medical Centre, Accra
Setshaba Research Centre, Soshanguve
University College London, London
Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka
COVID -19 Therapeutics Accelerator
UNKNOWN
Washington University School of Medicine
OTHER